Form 4: Quanterix Director Sarah E. Hlavinka Reports Stock and Option Transactions

Director Sarah E. Hlavinka of Quanterix Corp. reports acquisition of common stock and stock options, including restricted stock units, on January 2, 2025.

Summary

• Sarah E. Hlavinka, a director at Quanterix Corp, reported several transactions involving the company's stock on January 2, 2025.
• She acquired 7,435 shares of common stock through restricted stock units that will vest on December 31, 2025.
• Additionally, she acquired 1,394 shares of common stock in lieu of cash fees for her board service at a price of $10.76 per share.
• Hlavinka also received a non-qualified stock option to purchase 15,821 shares of common stock at an exercise price of $10.76, expiring on January 2, 2035.
• Following these transactions, she beneficially owns a total of 54,830 shares of common stock and 15,821 stock options.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment, as it reports standard insider transactions. There is no indication of positive or negative news, just routine activity.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
• The granting of stock options aligns the director's interests with those of the shareholders.

Industry Context

This is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the holdings and activities of company directors.

Comparison to Industry Standards

• Stock option grants and restricted stock units are standard forms of compensation for directors in publicly traded companies, particularly in the biotech sector.
• The vesting schedule of the restricted stock units is typical, with a one-year cliff vesting period.
• The exercise price of the stock options is at the market price on the grant date, which is a common practice.

Stakeholder Impact

• The transactions reported in this document provide transparency to shareholders regarding director compensation and holdings.
• The stock and option grants align the director's interests with those of the shareholders.

Key Dates

Keywords

Quanterix, stock options, restricted stock units, insider trading, director compensation, common stock, Form 4, equity